Corcept Preclinical Trials Show Corlux Prevents Weight Gain From Olanzapine

Corcept Therapeutics has announced results from two preclinical studies evaluating Corlux and its role in olanzapine-induced weight gain.

These studies were conducted in a rat model of olanzapine-induced weight gain. The studies show that Corlux has the potential to both reduce the weight gain caused by olanzapine and to prevent the weight gain caused by the initiation of treatment with olanzapine.